GM-CSF is well-known as a hemopoietic growth factor which has been used in patients with myelo-suppression due to chemotherapy, thereby potentially allowing tumor-bearing mice to recover from WBC reduction caused by metronomic chemotherapy. Here, CSF2 is linked to neoplasm.